Ron Balassanian, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Genentech
    Topic: 
    Patient education videos consultant
    Date added: 
    04/10/2023
    Relationship end date: 
    12/20/2022
  • Attribution: 
    Self
    Type of financial relationship: 
    Stock
    Ineligible company: 
    Cerus corp
    Topic: 
    $150 stock
    Date added: 
    04/10/2023
Return to 2023 Summit on Cancer Health Disparities: Reframing and Addressing Barriers to Adoption of Precision Oncology